Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL16151343 | 0.96 | TSHR (0.67) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL6416885 | 0.95 | TSHR (0.66) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL560438 | 0.95 | TSHR (0.81) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL6133312 | 0.94 | TSHR (0.64) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL6746745 | 0.93 | TSHR (0.66) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL561230 | 0.93 | TSHR (0.69) | TSHRHPGDCYP3A4TDP1ATM | |
| Ethylene SCHEMBL9340940 | 0.92 | TSHR (0.64) | TSHRHPGDCYP3A4TDP1ATM | |
| Acrylic Acid SCHEMBL516623 | 0.91 | TSHR (0.74) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL338002 | 0.91 | TSHR (0.88) | TSHRHPGDCYP3A4TDP1ATM | |
| SCHEMBL6134355 | 0.90 | TSHR (0.59) | TSHRHPGDCYP3A4TDP1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0586966-A2 | High cohesion waterborne pressure sensitive adhesives | National Starch and Chemical Investment Holding Corporation (US) | 1994-03-16 | — | — | EP | claimed |
| US-20050226919-A1 | Device for transdermal administration for the treatment of urinary tract disorders | UCB PHARMA GMBH (DE) | 2005-10-13 | — | — | US | disclosed |
| EP-1293198-B1 | Device for transdermal administration for the treatment of urinary tract disorders | SANOL ARZNEI SCHWARZ GMBH (DE) | 2005-02-09 | — | — | EP | disclosed |
| EP-0971994-B1 | PRESSURE-SENSITIVE ADHESIVES FOR MARKING FILMS | AVERY DENNISON CORP (US) | 2004-11-17 | — | — | EP | disclosed |
| US-6569949-B1 | Addition polymers; shell-core polymer | AVERY DENNISON CORPORATION | 2003-05-27 | — | — | US | disclosed |
| WO-2003024432-A2 | DEVICE FOR TRANSDERMAL ADMINISTRATION FOR THE TREATMENT OF URINARY TRACT DISORDERS | SCHWARZ PHARMA AG (DE) | 2003-03-27 | — | — | WO | disclosed |
| EP-1293198-A1 | Device for transdermal administration for the treatment of urinary tract disorders | SCHWARZ PHARMA AG (DE) | 2003-03-19 | — | — | EP | disclosed |
| US-6147165-A | INHERENTLY TACKY, POLYMER PARTICLES PREPARED BY EMULSION POLYMERIZATION OF A MIXTURE OF ALKYL ACRYLATE, AN UNSATURATED CARBOXY ACID, A STYRENIC MONOMER, SODIUM LAURYL ETHER SURFACTANT AND/OR SODIUM DIOCTYL SULFOSUCCINATE SURFACTANT | AVERY DENNISON CORPORATION (US) | 2000-11-14 | — | — | US | disclosed |
| US-5895801-A | CONSISTS OF FIRST POLYMER FORMED BY SEQUENTIAL EMULSION POLYMERIZATION CONSISTS OF A COPOLYMER OF C4 TO C12 ALKYL ACRYLATE, ATLEAST TWO UNSATURATED CARBOXYLIC ACID AND A THIRD HARD MONOMER, SECOND COPOLYMER OF ACRYLATE-UNSATURATED ACID | AVERY DENNISON CORPORATION (US) | 1999-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226919-A1 | Device for transdermal administration for the treatment of urinary tract disorders | AR, CYP17A1, TACR1 | TSHR 465/4885HPGD 287/4885CYP3A4 880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.